Key result
Raised serum fibrin degradation product levels were found in all cases of diagnosed deep vein thrombosis and pulmonary embolism among 76 high-risk surgical patients.
Why the study?
Does serum F.D.P. level correlate with the diagnosis of postoperative deep vein thrombosis and pulmonary embolism in high-risk surgical patients?
Observational (n=76)
Does serum F.D.P. level correlate with the diagnosis of postoperative deep vein thrombosis and pulmonary embolism in high-risk surgical patients?
Serum F.D.P. levels are significantly elevated in postoperative pulmonary embolism and may serve as a valuable diagnostic biomarker, though they are less useful for detecting deep vein thrombosis.
Answers are grounded in this paper and cite their sources.
May aid postoperative VTE diagnosis in high-risk patients; hypothesis-generating and should not yet change practice.
A total of 76 "high-risk" surgical patients were studied for evidence of venous thromboembolic disease. Episodes of deep vein thrombosis and of pulmonary embolism were related to changes in blood levels of fibrin degradation products (F.D.P.). When diagnosed either by ordinary clinical means or by venography and isotope scanning significantly raised F.D.P. levels were found in all cases. Serum F.D.P. estimations are unlikely to help in detecting deep vein thrombosis, but may prove valuable in diagnosing pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Ruckley et al. (1970) conducted an observational in Venous thromboembolic disease (n=76). Serum Fibrin/Fibrinogen Degradation Products (F.D.P.) was evaluated on Episodes of deep vein thrombosis and pulmonary embolism. Raised serum fibrin degradation product levels were found in all cases of diagnosed deep vein thrombosis and pulmonary embolism among 76 high-risk surgical patients.
Synapse has enriched 10 related papers. Consider them for comparative context: